0001193805-21-000157.txt : 20210210
0001193805-21-000157.hdr.sgml : 20210210
20210210083125
ACCESSION NUMBER: 0001193805-21-000157
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Payne Joseph E
CENTRAL INDEX KEY: 0001727315
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40034
FILM NUMBER: 21609394
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vallon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001824293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824369909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO LOGAN SQUARE
STREET 2: 100 N. 18TH STREET, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: (267) 207-3606
MAIL ADDRESS:
STREET 1: TWO LOGAN SQUARE
STREET 2: 100 N. 18TH STREET, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
3
1
e620264_3-payne.xml
X0206
3
2021-02-09
0
0001824293
Vallon Pharmaceuticals, Inc.
VLON
0001727315
Payne Joseph E
C/O VALLON PHARMACEUTICALS, INC.
100 N. 18TH STREET, SUITE 300
PHILADELPHIA
PA
19103
1
0
1
0
Common Stock
843750
I
By Arcturus Therapeutics, Inc.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Arcturus Therapeutics, Inc became the stockholder of record of the securities in connection with the liquidation of Arcturus Therapeutics, Ltd. as a result of the redomiciliation of Arcturus Therapeutics, Ltd. from Israel to the United States.
/s/ Ilan Katz, attorney-in-fact
2021-02-09